% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Herling:147215,
      author       = {C. D. Herling and K. R. Coombes and A. Benner$^*$ and J.
                      Bloehdorn and L. L. Barron and Z. B. Abrams and T. Majewski
                      and J. E. Bondaruk and J. Bahlo and K. Fischer and M. Hallek
                      and S. Stilgenbauer and B. A. Czerniak and C. C. Oakes and
                      A. Ferrajoli and M. J. Keating and L. V. Abruzzo},
      title        = {{T}ime-to-progression after front-line fludarabine,
                      cyclophosphamide, and rituximab chemoimmunotherapy for
                      chronic lymphocytic leukaemia: a retrospective, multicohort
                      study.},
      journal      = {The lancet / Oncology Oncology},
      volume       = {20},
      number       = {11},
      issn         = {1470-2045},
      address      = {London},
      publisher    = {The Lancet Publ. Group},
      reportid     = {DKFZ-2019-02341},
      pages        = {1576-1586},
      year         = {2019},
      note         = {20(11):1576-1586},
      abstract     = {Time-to-progression after front-line fludarabine,
                      cyclophosphamide, and rituximab chemoimmunotherapy for
                      chronic lymphocytic leukaemia: a retrospective, multicohort
                      study.},
      cin          = {C060},
      ddc          = {610},
      cid          = {I:(DE-He78)C060-20160331},
      pnm          = {313 - Cancer risk factors and prevention (POF3-313)},
      pid          = {G:(DE-HGF)POF3-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:31582354},
      doi          = {10.1016/S1470-2045(19)30503-0},
      url          = {https://inrepo02.dkfz.de/record/147215},
}